Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents
about
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance.Tools of the trade: investigations into design strategies of small molecules to target components in Alzheimer's disease.Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolismConjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer DiseaseModulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?Protection from neurodegeneration in the 6-hydroxydopamine (6-OHDA) model of Parkinson's with novel 1-hydroxypyridin-2-one metal chelators.
P2860
Q26748605-BF64B8FB-C3BA-488D-9219-DEB44D09AE56Q34153906-8AB9C4C6-8C34-494D-BF4E-0C5AF3D8A57FQ35577737-6686CF80-D254-4D37-9F1B-FDE032A7021BQ35978121-91365D0E-2810-4F46-AF2C-3E8835959627Q36273566-9BC8B18C-1A2B-44F0-968A-C295F3C0CC7EQ38032481-169CE039-32E5-4ABA-A820-694FF74A3018Q38086608-8476E0C4-787C-4E96-8E80-1A1E30C68546Q38898546-8B829B1F-5A3D-4253-B599-2BAA619B44DF
P2860
Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's diseases as disease modifying agents
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Why do we need multifunctional ...... es as disease modifying agents
@ast
Why do we need multifunctional ...... es as disease modifying agents
@en
type
label
Why do we need multifunctional ...... es as disease modifying agents
@ast
Why do we need multifunctional ...... es as disease modifying agents
@en
prefLabel
Why do we need multifunctional ...... es as disease modifying agents
@ast
Why do we need multifunctional ...... es as disease modifying agents
@en
P2860
P356
P1476
Why do we need multifunctional ...... es as disease modifying agents
@en
P2093
Moussa B H Youdim
P2860
P356
10.5607/EN.2010.19.1.1
P577
2010-06-30T00:00:00Z